secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardian Pharmacy Services, Inc. (GRDN)
CIK:        0001802255
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0001193125-26-102153
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardian Pharmacy Q4 revenue $397.6M (+17% YoY), net income $21.3M (+81%); raises 2026 EBITDA guidance
--------------------------------------------------------------------------------

- Q4 diluted EPS $0.33, adjusted EPS $0.37; full-year diluted EPS $0.78, adjusted EPS $1.07.
- Full-year revenue $1.45B (+18% YoY); net income $49.0M vs $71.0M loss in 2024.
- 2026 Adjusted EBITDA guidance raised to $120M–$124M (from $115M–$118M); revenue guidance unchanged $1.40B–$1.42B.
- Cash $65.6M at year-end, no long-term debt outstanding under $75M credit facility.
- Annualized return on equity approximately 27% in 2025; 54 full-service pharmacies after North Ridge acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802255/000119312526102153/0001193125-26-102153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802255/000119312526102153/d47713d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-102153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer